Intensity Therapeutics Signs Collaboration Agreement With The Swiss Group For Clinical Cancer Research SAKK To Conduct Phase 2 Breast Cancer Trial In Europe For INT230-6
Intensity Therapeutics 与瑞士临床癌症研究集团签署合作协议 SAKK 将在欧洲进行 INT230-6 的二期乳腺癌试验
Intensity Therapeutics Signs Collaboration Agreement With The Swiss Group For Clinical Cancer Research SAKK To Conduct Phase 2 Breast Cancer Trial In Europe For INT230-6
Intensity Therapeutics 与瑞士临床癌症研究集团签署合作协议 SAKK 将在欧洲进行 INT230-6 的二期乳腺癌试验
使用浏览器的分享功能,分享给你的好友吧